Enalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera
ABSTRACTObjective: Polycythemia Vera (PV) is a myeloproliferative neoplasm characterized by the overproduction of red blood cells. First-line therapies are directed at lowering hematocrit levels. After the discovery of a mutation in the Janus kinase 2 (JAK2V617F), JAK2 inhibitors have been tested as...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis Group
2023-12-01
|
| Seri Bilgileri: | Hematology |
| Konular: | |
| Online Erişim: | https://www.tandfonline.com/doi/10.1080/16078454.2023.2182056 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|